JP2002529430A - ベータ−アゴニストおよび他の抗糖尿病薬を含む組合せ - Google Patents

ベータ−アゴニストおよび他の抗糖尿病薬を含む組合せ

Info

Publication number
JP2002529430A
JP2002529430A JP2000580663A JP2000580663A JP2002529430A JP 2002529430 A JP2002529430 A JP 2002529430A JP 2000580663 A JP2000580663 A JP 2000580663A JP 2000580663 A JP2000580663 A JP 2000580663A JP 2002529430 A JP2002529430 A JP 2002529430A
Authority
JP
Japan
Prior art keywords
yloxy
insulin
ethylamino
carbazol
hydroxyethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000580663A
Other languages
English (en)
Japanese (ja)
Inventor
ジョナサン・ロバート・サンダース・アーチ
Original Assignee
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824789.3A external-priority patent/GB9824789D0/en
Priority claimed from GBGB9824790.1A external-priority patent/GB9824790D0/en
Priority claimed from GBGB9824791.9A external-priority patent/GB9824791D0/en
Application filed by スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー filed Critical スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー
Publication of JP2002529430A publication Critical patent/JP2002529430A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
JP2000580663A 1998-11-11 1999-11-11 ベータ−アゴニストおよび他の抗糖尿病薬を含む組合せ Withdrawn JP2002529430A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9824789.3A GB9824789D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GBGB9824790.1A GB9824790D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GBGB9824791.9A GB9824791D0 (en) 1998-11-11 1998-11-11 Novel methods of treatment
GB9824789.3 1998-11-11
GB9824790.1 1998-11-11
GB9824791.9 1998-11-11
PCT/GB1999/003755 WO2000027434A1 (en) 1998-11-11 1999-11-11 Combinations comprising a beta-agonist and a further antidiabetic agent

Publications (1)

Publication Number Publication Date
JP2002529430A true JP2002529430A (ja) 2002-09-10

Family

ID=27269550

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000580663A Withdrawn JP2002529430A (ja) 1998-11-11 1999-11-11 ベータ−アゴニストおよび他の抗糖尿病薬を含む組合せ

Country Status (15)

Country Link
EP (1) EP1128845A1 (hu)
JP (1) JP2002529430A (hu)
KR (1) KR20010075698A (hu)
CN (1) CN1332638A (hu)
AU (1) AU766928B2 (hu)
BR (1) BR9915214A (hu)
CA (1) CA2350062A1 (hu)
CZ (1) CZ20011655A3 (hu)
HK (1) HK1041201A1 (hu)
HU (1) HUP0104388A3 (hu)
IL (1) IL143004A0 (hu)
NO (1) NO20012300L (hu)
PL (1) PL348154A1 (hu)
TR (1) TR200101336T2 (hu)
WO (1) WO2000027434A1 (hu)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003518496A (ja) * 1999-12-23 2003-06-10 ノバルティス アクチエンゲゼルシャフト グルコース代謝障害を処置するための血糖降下薬の使用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007201729B2 (en) * 1999-12-23 2010-02-25 Novartis Ag Use of hypoglycemic agent for treating impaired glucose metabolism
WO2001047509A2 (en) * 1999-12-24 2001-07-05 Smithkline Beecham P.L.C. Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
EP1258253A1 (en) * 2000-01-28 2002-11-20 Asahi Kasei Kabushiki Kaisha Novel remedies with the use of beta3 agonist
AU2001252575A1 (en) * 2000-04-28 2001-11-12 Asahi Kasei Kabushiki Kaisha Novel tricyclic compounds
AU2001252573A1 (en) * 2000-04-28 2001-11-12 Asahi Kasei Kabushiki Kaisha Novel substituted tricyclic compounds
WO2006132196A1 (ja) * 2005-06-08 2006-12-14 Asahi Kasei Pharma Corporation β３作動薬を含有する新規な医薬
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0170416B1 (ko) * 1990-02-09 1999-02-18 로버트 에이. 아미테이지 고혈압 치료를 위한 인슐린 증감제의 용도
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
ATE251608T1 (de) * 1996-01-10 2003-10-15 Asahi Chemical Ind Neue trizyklische verbindungen und arzneimittelzusammensetzungen die diese enthalten

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003518496A (ja) * 1999-12-23 2003-06-10 ノバルティス アクチエンゲゼルシャフト グルコース代謝障害を処置するための血糖降下薬の使用

Also Published As

Publication number Publication date
NO20012300D0 (no) 2001-05-10
CA2350062A1 (en) 2000-05-18
TR200101336T2 (tr) 2001-11-21
WO2000027434A1 (en) 2000-05-18
EP1128845A1 (en) 2001-09-05
KR20010075698A (ko) 2001-08-09
CZ20011655A3 (cs) 2002-06-12
AU766928B2 (en) 2003-10-23
NO20012300L (no) 2001-07-03
PL348154A1 (en) 2002-05-06
BR9915214A (pt) 2001-12-18
HK1041201A1 (zh) 2002-07-05
CN1332638A (zh) 2002-01-23
HUP0104388A3 (en) 2002-12-28
IL143004A0 (en) 2002-04-21
AU1063400A (en) 2000-05-29
HUP0104388A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
JP2003535898A (ja) 真性糖尿病の治療用のジペプチジルペプチダーゼｉｖ阻害剤および他の抗糖尿病剤の組み合わせ
KR100666591B1 (ko) 티아졸리딘디온 및 메트포르민을 사용한 당뇨병의 치료
KR100643833B1 (ko) 인슐린 감작제 및 다른 항당뇨병 약제의 개선된 방출을위한 제약 조성물
JP2005213273A (ja) チアゾリジンジオン、インスリン分泌促進薬およびジグアニドを用いる糖尿病の治療
JP2005247865A (ja) チアゾリジンジオンおよびスルホニル尿素を用いる糖尿病の治療
JP2002529430A (ja) ベータ−アゴニストおよび他の抗糖尿病薬を含む組合せ
JP2001510160A (ja) チアゾリジンジオン、インスリン分泌促進薬およびアルファグルコシダーゼ阻害剤を用いる糖尿病の治療
JP2001523270A (ja) チアゾリジンジオンおよびスルホニルウレアを用いる糖尿病の治療
JP2001523271A (ja) チアゾリジンジオンおよびアルファ−グルコシダーゼ阻害剤を用いる糖尿病の治療
US20030073644A1 (en) Combinations comprising a beta-agonist and a further antidiabetic agent
US20030109561A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
MXPA01004826A (en) Combinations comprising a beta-agonist and a further antidiabetic agent
JP2001519383A (ja) 高血糖症治療のためのチアゾリジンジオンの使用
ZA200103792B (en) Combinations comprising a beta-agonist and a further antidiabetic agent.
MXPA00000655A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
MXPA00000631A (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
MXPA00000633A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
CZ2000172A3 (cs) Léčivo pro léčbu diabetes mellitus a stavů s diabetes mellitus spojených a farmaceutický prostředek
KR20010024481A (ko) 고혈당증 치료용 티아졸리딘디온의 용도

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061113

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20090423